Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
HUMULIN R ELI LILLY CANADA INC Actual shortage 100UNIT Updated Report 2024-04-23 225163
ULTRAVIST 370 BAYER INC Actual shortage 77% Updated Report 2024-04-23 218759
ULTRAVIST 370 BAYER INC Actual shortage 77% Updated Report 2024-04-23 215787
SANDOZ POSACONAZOLE SANDOZ CANADA INCORPORATED Actual shortage 100MG Updated Report 2024-04-23 218024
SANDOZ OLMESARTAN SANDOZ CANADA INCORPORATED Actual shortage 20MG Updated Report 2024-04-23 223197
ESTALIS 250/50 MCG SANDOZ CANADA INCORPORATED Actual shortage 250MCG 50MCG Updated Report 2024-04-23 216175
SANDOZ ZOLMITRIPTAN ODT SANDOZ CANADA INCORPORATED Anticipated shortage 2.5MG New Report 2024-04-23 225976
SANDOZ TIMOLOL SANDOZ CANADA INCORPORATED Anticipated shortage 0.25% New Report 2024-04-23 225972
SANDOZ LEVOFLOXACIN SANDOZ CANADA INCORPORATED Anticipated shortage 250MG New Report 2024-04-23 225968
SANDOZ EVEROLIMUS SANDOZ CANADA INCORPORATED Anticipated shortage 5MG New Report 2024-04-23 225965
SANDOZ DEFERASIROX (TYPE J) SANDOZ CANADA INCORPORATED Anticipated shortage 360MG New Report 2024-04-23 225962
SANDOZ CLONIDINE SANDOZ CANADA INCORPORATED Anticipated shortage 0.1MG New Report 2024-04-23 225959
CLINDAMYCIN IV INFUSION SANDOZ CANADA INCORPORATED Anticipated shortage 18MG New Report 2024-04-23 225956
SANDOZ AMIODARONE SANDOZ CANADA INCORPORATED Anticipated shortage 200MG New Report 2024-04-23 225953
OMNIPAQUE 240 GE HEALTHCARE CANADA INC Anticipated shortage 518MG New Report 2024-04-23 225946
SANDOZ OLOPATADINE 0.2% SANDOZ CANADA INCORPORATED Actual shortage 0.2% Updated Report 2024-04-23 222614
SANDOZ LEVOFLOXACIN SANDOZ CANADA INCORPORATED Actual shortage 750MG Updated Report 2024-04-23 205153
SANDOZ EZETIMIBE SANDOZ CANADA INCORPORATED Actual shortage 10MG Updated Report 2024-04-23 222611
PHENOBARBITAL SODIUM INJECTION, USP SANDOZ CANADA INCORPORATED Actual shortage 120MG Updated Report 2024-04-23 221838
SANDOZ-DICLOFENAC SANDOZ CANADA INCORPORATED Actual shortage 50MG Updated Report 2024-04-23 215326

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
DULOXETINE SANIS HEALTH INC Reversed 30MG Updated Report 2024-04-23 219618
LIDOCAINE HYDROCHLORIDE INJECTION USP HIKMA CANADA LIMITED Discontinued 10MG Updated Report 2024-04-22 225805
STRATTERA ELI LILLY CANADA INC To be discontinued 18MG Updated Report 2024-04-19 171480
MYLAN-VERAPAMIL MYLAN PHARMACEUTICALS ULC Discontinued 80MG Updated Report 2024-04-12 224846
TD ADSORBED SANOFI PASTEUR LIMITED To be discontinued 5LF 2LF Updated Report 2024-04-10 206909
PEDIACEL SANOFI PASTEUR LIMITED To be discontinued 5MCG 20MCG 30MCG 10MCG 32UNIT 8UNIT 40UNIT 5LF 15LF 20MCG 3MCG Updated Report 2024-04-10 206912
DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% AMD MEDICOM INC Discontinued 0.12% New Report 2024-04-09 224698
DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% AMD MEDICOM INC Discontinued 0.12% Updated Report 2024-04-09 224713
PAXIL TAB 30MG GLAXOSMITHKLINE INC To be discontinued 30MG New Report 2024-04-05 224430
PAXIL TAB 10MG GLAXOSMITHKLINE INC To be discontinued 10MG New Report 2024-04-05 224405